BALTIMORE, MDGastric cancer often remains undiagnosed until it has reached an advanced and incurable stage and, until recently, little evidence to direct optimal therapeutic approaches was available. Oncologists face the challenges of incorporating recent and emerging clinical data into practice as well as developing individualized treatment regimens to address the needs and goals of patients with advanced gastric cancer.

To help physicians better implement contemporary evidence into patient care, Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), has released a complimentary, CME-certified educational series that follows Harold, a fictional patient with newly diagnosed advanced gastric cancer, through the course of disease. Case Explorations in the Treatment of Advanced Gastric Cancer: A Clinical CliffhangersSM Series is an interactive, unique platform that presents realistic clinical scenarios and involves participants in Harold’s management. For instance, clinicians can identify first-line treatment approaches for this patient case, see how their selections compare with an expert’s, and review current evidence-based patient-monitoring strategies for disease- and treatment-related effects.

Webisode 1: Selecting Optimal Therapy in the First-Line Setting
Webisode 2: Examining Treatment Approaches to Progressive Disease

“In this Clinical Cliffhangers series, learners can review up-to-date clinical trial data and guideline recommendations and make treatment decisions about a case that is representative of this type of malignancy,” said Johanna Bendell, MD, director of GI Oncology Research at the Sarah Cannon Research Institute in Nashville, TN. “The interactive nature of this educational model enables clinicians to apply recent evidence not only to Harold’s case, but also to their own clinical practice.”

To access this free educational opportunity, visit For more information, please call (toll-free) 866 858 7434 or e-mail


Johanna Bendell, MD
Director, GI Oncology Research
Associate Director, Drug Development Unit
Sarah Cannon Research Institute
Tennessee Oncology
Nashville, TN

This series is approved for AMA PRA Category 1 Credit™.

This series is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit


About Med-IQ

Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.

As a leader in the CME industry, Med-IQ has delivered 32 performance improvement (PI) and quality improvement (QI) initiatives that make use of systems-based training such as Crew Resource Management (CRM) to improve team performance and patient outcomes. These initiatives have achieved improvement in healthcare professional performance, quality of care, and patient outcomes. Med-IQ’s work in this space has been published 30 times in peer-reviewed journals, and the company has been recognized by the Alliance for Continuing Education in the Health Professions for excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership and contributions to the CE profession (Leadership Award 2015, 2013; Distinguished Fellow Award 2015; President’s Award 2015, 2012; Rising Star Award 2015). To learn more about Med-IQ, visit, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.

For more information, contact:

Amy Caswell
Senior Audience Development Manager
866 858 7434

Inspiring Medical Education.